Plant-Derived Nanovesicles for Scalable HBsAg Antigen Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current vaccine delivery systems, particularly those using mammalian-derived nanovesicles, face challenges in mass production and stability, limiting their effectiveness as delivery tools for antigens like hepatitis B virus surface antigens (HBsAg).
Innovation Solution
Utilizing plant-derived nanovesicles, specifically from grapefruits and mandarin oranges, to enhance antigen delivery efficiency by loading HBsAg into these nanovesicles, which are then administered for improved vaccine efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If mammalian-derived nanovesicles are used as delivery tools, then antigen delivery can be achieved, but mass production is difficult and stability is poor
Solution Approach 1:
The patent replaces expensive, difficult-to-produce mammalian-derived nanovesicles with inexpensive, easily producible plant-derived nanovesicles. The plant nanovesicles can be mass-produced from edible plants like grapefruits and mandarin oranges, solving both the productivity and stability issues simultaneously.
2Productivity
If plant-derived nanovesicles are used, then mass production and stability are improved, but research and application are insufficient
Solution Approach 1:
The patent demonstrates that plant-derived nanovesicles can autonomously deliver antigens to immune cells without requiring complex external delivery systems. The nanovesicles naturally interact with immune cells and facilitate antigen presentation, making them a complete, self-sufficient delivery solution that is ready for practical application.
3Ease of operation
If antigens are administered alone, then administration is simple, but antigen delivery efficiency is lower
Solution Approach 1:
The patent introduces plant-derived nanovesicles as an intermediary carrier between the antigen and immune cells. The nanovesicles protect the antigen during administration and facilitate its uptake by immune cells, thereby enhancing delivery efficiency while maintaining the simplicity of the administration process.
Data Source
AI summary
Proposed is a drug-delivery composition including plant-derived nanovesicles as an active ingredient. It was confirmed that antigen (drug) delivery efficiency is higher when the antigens are loaded into nanovesicles isolated from grapefruits or mandarin oranges, and the loaded antigens are administered rather than administering hepatitis B virus surface antigens (HBsAg) alone. Thus, the nanovesicles can be useful as a drug-delivery composition.